Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review
European Psychiatry April 1, 2024 N. Kabir, B. Anderson, Lisa Bouchet et al. 1 citation
Introduction Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and post-traumatic stress disorder. Objectives...